Literature DB >> 32538858

Dementia in the COVID-19 Period.

Amos D Korczyn1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32538858      PMCID: PMC7369036          DOI: 10.3233/JAD-200609

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


× No keyword cloud information.
While we are witnessing the huge effects of the present corona pandemic, let us not forget that large as it is, its size is small relative to that of dementia, labeled by the World Health Organization as a public health priority. Yet, the huge investments in the COVID-19 illness are much higher than those dedicated to dementia research and treatment. This is in spite of the fact that the SARS-CoV-2 will disappear soon, like previous Corona viruses, or an immunization against it will be developed. On the other hand, the dementia epidemic is getting bigger all the time because of the aging of the population, prolonged survival, and other factors. However, the effects of the COVID-19 infection on those older people who have cognitive decline (due to Alzheimer’s disease or other causes) need to be addressed. This is not restricted to those cognitively impaired people who happen to become infected by the virus. The draconic measures inflicted on the population at large impose an disproportionate burden on the elderly and particularly on those with cognitive impairment. The restrictions to move about and meet friends and family members are incomprehensible to them. The explanations given are not well understood and, in any case, soon forgotten, leading to stress on patients and caregivers. The risk factors for dementia in general, age, obesity, cardiovascular disease, hypertension, and diabetes mellitus, are also the major risk factors for COVID-19, making persons with cognitive impairment particularly vulnerable to the SARS-CoV-2 infection, and quite likely making the disease more severe. Therefore, these people need to maintain rigid control, and this applies even more to those who reside in retirement facilities or nursing homes. The availability of virtual communication such as Skype or Zoom facilitates contact with those persons [1], although we should not forget that physical contact is very important and can only partially be replaced by electronic communication, even more so since the elderly are computer-naïve and because of cognitive limitations may have difficulties in absorbing and being able to incorporate new technologies. In any case, the imposed physical isolation should not imply also social isolation. In fact, human contact is so important that it should be encouraged and enhanced. The effects of the imposed isolation are likely to induce or exacerbate depression, anxiety, and stress, possibly reflected by aggression. The stress is considered to be detrimental to people with cognitive impairment [2] and may lead to a cytokine release syndrome which is potentially dangerous, and needs to be avoided. It is obvious that alleviating measures should be implemented, as far as possible, before the stress is expressed. Most relevant are behavioral measures. Once patients with cognitive impairment, mild, or more severe dementia are diagnosed with COVID-19, a critical question is whether they need to be hospitalized. Whatever their condition, there is a chance that they will be transferred to an intensive care facility where they will be isolated and treated by unfamiliar persons wearing masks and dressed in astronauts-like cloths. There is little time for explanations and this is particularly true for those people whose understanding is impaired. Many of them will develop restlessness, agitation, and attempt to free themselves, requiring pharmacological sedation, which will further impair their oxygenation leading to intubation under anesthesia. The consequences of prolonged anesthesia are dire. Mortality is high and the survivors may show cognitive deterioration and possibly post-traumatic stress disorder. Unfortunately, only a minority of people with cognitive impairment have signed advanced directive forms. Even if they have mild cognitive impairment, by the time they arrive at the hospital door it may be too late to discuss the issue with them. The time available is too short, and they are under stress as well as possibly hypoxemic which is not conductive to have a serious discussion aiming to receive an informed consent to any intervention. Given the harsh prognosis once admitted to hospital, it may be better if people with cognitive impairment who develop COVID-19 remain at their residence and be treated there [3, 4].

DISCLOSURE STATEMENT

The author’s disclosure is available online (https://www.j-alz.com/manuscript-disclosures/20-0609).
  4 in total

Review 1.  Pandemic palliative care: beyond ventilators and saving lives.

Authors:  Amit Arya; Sandy Buchman; Bruno Gagnon; James Downar
Journal:  CMAJ       Date:  2020-03-31       Impact factor: 8.262

Review 2.  The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders.

Authors:  Bastiaan R Bloem; E Ray Dorsey; Michael S Okun
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

3.  Covid-19 - A Reminder to Reason.

Authors:  Ivry Zagury-Orly; Richard M Schwartzstein
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

4.  Psychological distress and risk for dementia.

Authors:  Martine Simard; Carol Hudon; Robert van Reekum
Journal:  Curr Psychiatry Rep       Date:  2009-02       Impact factor: 5.285

  4 in total
  10 in total

1.  Telemedicine and Virtual Reality at Time of COVID-19 Pandemic: An Overview for Future Perspectives in Neurorehabilitation.

Authors:  Marta Matamala-Gomez; Sara Bottiroli; Olivia Realdon; Giuseppe Riva; Lucia Galvagni; Thomas Platz; Giorgio Sandrini; Roberto De Icco; Cristina Tassorelli
Journal:  Front Neurol       Date:  2021-03-25       Impact factor: 4.003

Review 2.  Coping with Dementia in the Middle of the COVID-19 Pandemic.

Authors:  Nayoung Ryoo; Jung Min Pyun; Min Jae Baek; Jeewon Suh; Min Ju Kang; Min Jeong Wang; Young Chul Youn; Dong Won Yang; Seong Yoon Kim; Young Ho Park; SangYun Kim
Journal:  J Korean Med Sci       Date:  2020-11-02       Impact factor: 2.153

Review 3.  Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19.

Authors:  Dipak Kumar; Sadaf Jahan; Andleeb Khan; Arif Jamal Siddiqui; Neeru Singh Redhu; Johra Khan; Saeed Banwas; Bader Alshehri; Mohammed Alaidarous
Journal:  Mol Neurobiol       Date:  2021-03-14       Impact factor: 5.590

Review 4.  Dementia in the era of COVID-19. Some considerations and ethical issues.

Authors:  Gabriele Cipriani; Mario Di Fiorino; Davide M Cammisuli
Journal:  Psychogeriatrics       Date:  2021-11-14       Impact factor: 2.295

5.  Relationship between dementia, COVID-19 risk, and adherence to COVID-19 mitigation behaviors among older adults in the United States.

Authors:  Roger Wong; Margaret Anne Lovier
Journal:  Int J Geriatr Psychiatry       Date:  2022-06       Impact factor: 3.850

6.  'I want every minute to be worthwhile now': The views and experiences of people living with dementia and their care partners about returning to in-person group meetings after COVID-19 lockdown restrictions.

Authors:  Siobhán Kelly; Sophie Bushell; Anthea Innes
Journal:  Dementia (London)       Date:  2022-08-16

7.  "We Don't Feel so Alone": A Qualitative Study of Virtual Memory Cafés to Support Social Connectedness Among Individuals Living With Dementia and Care Partners During COVID-19.

Authors:  Sara S Masoud; Kylie N Meyer; Lauryn Martin Sweet; Patricia J Prado; Carole L White
Journal:  Front Public Health       Date:  2021-05-13

8.  [Position paper of the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft, ÖAG) : Effects of the COVID-19 pandemic in Austria on people with dementia and their care environment-problem areas, recommendations, and strategies].

Authors:  Michaela Defrancesco; Christian Bancher; Peter Dal-Bianco; Hartmann Hinterhuber; Reinhold Schmidt; Walter Struhal; Gerhard Ransmayr; Elisabeth Stögmann; Josef Marksteiner
Journal:  Neuropsychiatr       Date:  2020-10-29

9.  Prevention and Management of COVID-19 in Patients with Dementia Living at Home: Experience from China.

Authors:  Renjun Lv; Qingqing Yin
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

10.  Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.

Authors:  Mariantonietta Pisaturo; Federica Calò; Antonio Russo; Clarissa Camaioni; Agnese Giaccone; Biagio Pinchera; Ivan Gentile; Filomena Simeone; Angelo Iodice; Paolo Maggi; Nicola Coppola
Journal:  Front Aging Neurosci       Date:  2021-06-29       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.